Neuroendocrine tumor epidemiology: Contrasting Norway and North America

Cancer

Volumn 113, Issue 10, 2008, Pages 2655-2664

  Hauso, Oyvind ^a,b   Gustafsson, Bjorn I ^a,b   Kidd, Mark ^a   Waldum, Helge L ^b   Drozdov, Ignat ^a   Chan, Anthony K C ^c   Modlin, Irvin M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Carcinoid; Epidemiology; Neuroendocrine; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; NORTH AMERICA; NORWAY; PRIORITY JOURNAL;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; NEUROENDOCRINE TUMORS; NORTH AMERICA; NORWAY; REGISTRIES; SEER PROGRAM; SEX DISTRIBUTION;

EID: 55849088735     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23883     Document Type: Article

References (41)

1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934-959.
2. Oberndorfer S. Karzinoide tumoren des dunndarms. Frankf Z Pathol. 1907;1:426-432.
3. Gosset A, Masson P. Tumeurs endocrines de l'appendice. Presse Med. 1914;25:237-240.
4. Langhans T. Ueber einen Drusenpolyp im Ileum. Virchow Archiv Pathol Anatom Physiol Klin Med. 1867;38: 550-560.
5. Lubarsch O. Ueber dem primaren Krebs des Ileum nebst Bemerkungen uber das gleichzeitige Vorkommen von Krebs und Tuberculose. Virchow Archiv Pathol Anatom Physiol Klin Med. 1888;111:280-317.
6. Ransom WB. A case of primary carcinoma of the ileum. Lancet. 1890;2:1020-1023.
7. Maggard MA, O'Connell JB, Ko CY. Updated populationbased review of carcinoid tumors. Ann Surg. 2004;240:117-122.
8. Perez EA, Koniaris LG, Snell SE, et al. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg. 2007;31:1022-1030.
9. Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer. 2001;92:2204-2210.
10. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61-72.
11. Cancer Registry of Norway. Cancer in Norway 2005. Oslo, Norway: Institute of Population Based Cancer Research. Available at: http://www.kreftregisteret. no/no/Generelt/ Publikasjoner/Cancer-in-Norway/Cancer-in-Norway-2005/ Accessed December 2006.
12. Statistisk Sentralbyra. Statistical Yearbook of Norway. Statistics Norway. 2005. Available at: http://www.ssb.no/aarbok/ 2005/
13. US Department of Health and Human Services. Health, United States, 2006. Available at: http://www.cdc.gov/nchs/ fastats/lifexpec.htm
14. He W, Sengupta M, Velkoff VA, DeBarros KA. National Institutes of Health. 651 in the United States: 2005. 2006. Available at: http://www.census.gov/prod/ 2006pubs/p23-209. pdf Accessed December 2005.
15. DeNavas-Walt C, Proctor BD, Lee CH. US Census Bureau. Income, Poverty, and Health Insurance Coverage in the United States: 2006. Available at: http://www.census.gov/ prod/2006pubs/p60-231.pdf Accessed August 2006.
16. Grunkemeier GL, Anderson RP, Starr A. Actuarial and actual analysis of surgical results: empirical validation. Ann Thorac Surg. 2001;71:1885-1887.
17. Neuhausen SL. Ethnic differences in cancer risk resulting from genetic variation. Cancer. 1999;86(11 suppl):2575-2582.
18. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM. The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer. 2005;104:2292-2309.
19. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395-401.
20. US National Cancer Institute. Surveillance Epidemiology and End Results (SEER) database, 1973-2004. Available at: http://seer.cancer.gov/ Accessed April 2007.
21. Centers for Disease Control and Prevention. Tobacco use among adults-United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:1145-1148.
22. Centers for Disease Control and Prevention. Tobacco use - United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:986-993.
23. Ronneberg A, Lund KE, Hafstad A. Lifetime smoking habits among Norwegian men and women born between 1890 and 1974. Int J Epidemiol. 1994;23:267-276.
24. Modlin IM, Kidd M, Pfragner R, Eick GN, Champaneria MC. The functional characterization of normal and neoplastic human enterochromaffin cells. J Clin Endocrinol Metab. 2006;91:2340-2348.
25. Godwin JD II. Carcinoid tumors. An analysis of 2,837 cases. Cancer. 1975;36:560-569.
26. Fahy BN, Tang LH, Klimstra D, et al. Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment. Ann Surg Oncol. 2007;14:1735-1743.
27. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol. 2004;99:23-32.
28. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis. 2007;8:179-185.
29. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56:1-9.
30. Waldum HL, Gustafsson B, Fossmark R, Qvigstad G. Antiulcer drugs and gastric cancer. Dig Dis Sci. 2005;50(suppl 1): S39-S44.
31. Kidd M, Modlin IM, Black JW, Boyce M, Culler M. A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation. Regul Pept. 2007;143:109-117.
32. Monkemuller K, Fry LC, Malfertheiner P. Pancreatic cancer is 'always non-resectable'. Dig Dis. 2007;25:285-288.
33. Soga J. Carcinoids of the pancreas: an analysis of 156 cases. Cancer. 2005;104:1180-1187.
34. Sandor A, Modlin IM. A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastroenterol. 1998;93:422-428.
35. Taal BG, Smits M. Developments in diagnosis and treatment of metastatic midgut carcinoid tumors. A review. Minerva Gastroenterol Dietol. 2005;51:335-344.
36. Tang LH, Klimstra DS. Carcinoid tumors of the appendix. In: Modlin IM, Öberg K, eds. A Century of Advances in Neuroendocrine Tumor Biology and Treatment. Montreaux: Felsenstein, C.C.C.P., 2008:112-123.
37. McGory ML, Maggard MA, Kang H, O'Connell JB, Ko CY. Malignancies of the appendix: beyond case series reports. Dis Colon Rectum. 2005;48:2264-2271.
38. Upalakalin JN, Collins LC, Tawa N, Parangi S. Carcinoid tumors in the breast. Am J Surg. 2006;191:799-805.
39. Yuan TC, Veeramani S, Lin MF. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr Relat Cancer. 2007; 14:531-547.
40. Angelsen A, Syversen U, Haugen OA, Stridsberg M, Mjolnerod OK, Waldum HL. Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings? Prostate. 1997;30:1-6.
41. Murali R, Kneale K, Lalak N, Delprado W. Carcinoid tumors of the urinary tract and prostate. Arch Pathol Lab Med. 2006;130:1693-1706.